BCM
BIIB icon

Boltwood Capital Management’s Biogen BIIB Stock Holding History

Boltwood Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$448K Buy
1,982
+493
+33% +$105K 0.1% 147
2026
Q2 		$322K Buy
1,489
+215
+17% +$41.1K 0.07% 160
2026
Q1 		$234K Buy
1,274
+133
+12% +$24.5K 0.06% 174
2025
Q4 		$201K Buy
+1,141
New +$186K 0.05% 181
2024
Q4 		– Sell
-1,197
Closed -$232K – 171
2024
Q3 		$232K Sell
1,197
-7
-0.6% -$1.46K 0.07% 157
2024
Q2 		$279K Sell
1,204
-56
-4% -$12.2K 0.09% 147
2024
Q1 		$272K Buy
1,260
+13
+1% +$3.04K 0.08% 150
2023
Q4 		$323K Sell
1,247
-10
-0.8% -$2.46K 0.11% 138
2023
Q3 		$323K Sell
1,257
-11
-0.9% -$2.94K 0.12% 124
2023
Q2 		$361K Sell
1,268
-20
-2% -$5.95K 0.13% 125
2023
Q1 		$358K Sell
1,288
-2
-0.2% -$553 0.13% 121
2022
Q4 		$357K Sell
1,290
-27
-2% -$7.63K 0.15% 117
2022
Q3 		$352K Buy
1,317
+60
+5% +$12.7K 0.16% 114
2022
Q2 		$256K Buy
+1,257
New +$257K 0.11% 135
2019
Q2 		– Sell
-2,116
Closed -$500K – 129
2019
Q1 		$500K Buy
2,116
+129
+6% +$40.6K 0.33% 89
2018
Q4 		$597K Sell
1,987
-39
-2% -$12.4K 0.41% 78
2018
Q3 		$715K Buy
2,026
+37
+2% +$12.7K 0.43% 84
2018
Q2 		$577K Buy
1,989
+45
+2% +$12.7K 0.38% 87
2018
Q1 		$532K Sell
1,944
-41
-2% -$12.7K 0.36% 86
2017
Q4 		$632K Sell
1,985
-625
-24% -$201K 0.39% 79
2017
Q3 		$817K Buy
2,610
+50
+2% +$14.8K 0.53% 64
2017
Q2 		$694K Buy
2,560
+100
+4% +$26.4K 0.47% 70
2017
Q1 		$672K Buy
2,460
+380
+18% +$107K 0.47% 71
2016
Q4 		$589K Sell
2,080
-20
-1% -$5.93K 0.45% 75
2016
Q3 		$657K Buy
2,100
+55
+3% +$16.3K 0.53% 64
2016
Q2 		$495K Buy
2,045
+125
+7% +$32.9K 0.41% 74
2016
Q1 		$500K Buy
+1,920
New +$507K 0.44% 73

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Boltwood Capital Management's BIIB Position: Q3 2026 in Review

Boltwood Capital Management increased its Biogen (BIIB) stake by 33% in Q3 2026, buying an estimated $105K and bringing the position to 1,982 shares worth $448K. The position accounts for 0.1% of the portfolio, ranked #147.

Boltwood Capital Management first reported a position in BIIB in Q1 2016 and has held it in 27 quarters since. The position peaked at $817K in Q3 2017. 32 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Boltwood Capital Management held 1,982 shares of Biogen worth $448K as of Q3 2026.
  • Boltwood Capital Management bought 493 Biogen shares in Q3 2026, an estimated $105K.
  • Biogen made up 0.1% of Boltwood Capital Management's portfolio in Q3 2026, its #147 holding.
  • Boltwood Capital Management first reported a position in Biogen in Q1 2016 and has held it in 27 quarters since.
  • Boltwood Capital Management's Biogen position peaked at $817K in Q3 2017.
  • 32 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Boltwood Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.